New antithrombotics with an indazole structure.

Arch Pharm (Weinheim)

Institut für Pharmazie, Freie Universität Berlin, Berlin, Germany.

Published: June 2004

AI Article Synopsis

  • Fifteen new indazole derivatives were synthesized, with compounds (4f) and (4g) showing the highest activity in inhibiting collagen-induced blood platelet aggregation (IC(50) = 85 or 90 µM).
  • Oral administration of these compounds to rats (60 mg/kg) resulted in a significant reduction in thrombus formation in arterioles and venules, with compound (4j) showing the most substantial effects (15% in arterioles, 7% in venules).
  • Further studies indicated that compound (4j) likely exerts its effects by inhibiting phosphodiesterase isoform PDE 5, rather than activating soluble guanylate cyclase.

Article Abstract

Fifteen new indazole derivatives have been synthesized. In the Born test, compounds (4f) and (4g) were most active. They inhibited the blood platelet aggregation induced by collagen with an IC(50) = 85 or 90 microM, respectively. After oral administration to rats (60 mg/kg) three of the compounds significantly inhibited the formation of thrombi in arterioles and venules. The strongest effect was observed with (4j) which showed an inhibition of 15% in arterioles and 7% in venules. Further experiments showed that compound (4j) does not mediate these effects by activating soluble guanylate cyclase, but likely by inhibiting phosphodiesterase isoform PDE 5.

Download full-text PDF

Source
http://dx.doi.org/10.1002/ardp.200300832DOI Listing

Publication Analysis

Top Keywords

arterioles venules
8
antithrombotics indazole
4
indazole structure
4
structure fifteen
4
fifteen indazole
4
indazole derivatives
4
derivatives synthesized
4
synthesized born
4
born test
4
test compounds
4

Similar Publications

Retinal microvascular dysfunction in systemic sclerosis.

Microvasc Res

December 2024

Department of Cardiology, University Heart Center, University Hospital and University of Zurich, Zurich, Switzerland; Center for Translational and Experimental Cardiology (CTEC), Department of Cardiology, University Hospital Zurich, University of Zurich, Zurich, Switzerland. Electronic address:

Background And Aims: Systemic sclerosis (SSc) is a systemic autoimmune disease, characterized by widespread microvasculopathy and fibrosis. Vascular and endothelial cell changes appear to precede other features of SSc. Retinal vascular analysis is a new, easy-to-use tool for the assessment of retinal microvascular function.

View Article and Find Full Text PDF

The integrity of the blood-retina barrier (BRB) is crucial for phototransduction and vision, by tightly restricting transport of molecules between the blood and surrounding neuronal cells. Breakdown of the BRB leads to the development of retinal diseases. Here, we show that Netrin-1/Unc5b and Norrin/Lrp5 signaling establish a zonated endothelial cell gene expression program that controls BRB integrity.

View Article and Find Full Text PDF

Purpose: To investigate local hemodynamic changes resulting from elevated intraocular pressure (IOP) in different vasculature networks using a computational fluid dynamics model based on 3D reconstructed confocal microscopic images.

Methods: Three-dimensional rat retinal vasculature was reconstructed from confocal microscopy images using a 3D U-Net-based labeling technique, followed by manual correction. We conducted a computational fluid dynamics (CFD) analysis on different retinal vasculature networks derived from a single rat.

View Article and Find Full Text PDF

Purpose: To evaluate ECG-gated retinal vessel calibre as a novel measure of aberrant pulsatile retinal flow in diabetes mellitus.

Methods: A novel mydriatic ECG-gated fundoscope was used to acquire retinal vessel calibre measurements at four cardiac cycle time points from end diastole to early diastole. An inhouse software recorded the exact time when an image was captured to corroborate ECG-synchronisation.

View Article and Find Full Text PDF

Background: The mechanism of how sacubitril/valsartan improves outcomes in heart failure with reduced ejection fraction (HFrEF) is still incompletely understood.

Objectives: The aim of this trial was to delineate the effects of sacubitril/valsartan on endothelial function, retinal microvascular function, and arterial stiffness in HFrEF.

Methods: This double-blind controlled trial randomized 79 stable HFrEF patients with NYHA class II-IV on guideline-recommended therapy (mean age: 59.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!